Management
Srinivasa Nagalla, MD
PRESIDENT AND CHIEF EXECUTIVE OFFICERDr. Nagalla is the principal founder and chief executive officer of Diabetomics. He was previously founder and CEO of ProteoGenix, Inc., a successful innovator in maternal-fetal health diagnostics, which was acquired by Hologic, Inc. (HOLX) in 2010. Before founding ProteoGenix, Dr. Nagalla was Associate Professor of Pediatrics at Oregon Health & Science University. He is the lead inventor on several key patents on biomarkers for clinical diagnostics, and has previously served on National Institutes of Health-sponsored national consortiums on biotechnology, genomics, and proteomics. Dr. Nagalla has over 25 years of broad, multi-disciplinary experience in clinical medicine, biotechnology, and commercialization. Dr. Nagalla received his MD from the All-India Institute of Medical Sciences in New Delhi, and post-doctoral training at Harvard University and Oregon Health & Science University.
Barbara Chiapuzio
CHIEF FINANCIAL OFFICERMs. Chiapuzio brings over 20 years of experience growing privately-held entrepreneurial environments in a range of industries including technology, software-as-a-service and manufacturing. Prior to joining Diabetomics, Ms. Chiapuzio served as chief financial officer of Smarsh, a software-as-a-service company providing archiving and compliance solutions, and as chief financial officer of Network Elements, a manufacturer of optical modules. She was vice president of finance at Claremont Technology Group, an IT consulting firm, where she played a leading role in the company’s IPO process. She began her career in public accounting at KPMG. Ms. Chiapuzio holds a BS in Business Administration with a concentration in Accounting from Portland State University.
Charles Roberts, PhD
VICE PRESIDENT AND CHIEF SCIENCE OFFICERDr. Roberts is co-founder and chief science officer since 2008. Dr. Roberts is a molecular endocrinologist with over 30 years of experience in diabetes research, is an internationally recognized expert on insulin action, and has authored over 250 scientific papers and review articles. Dr. Roberts is also a co-inventor on various patents on therapeutics and biomarkers for clinical diagnostics, and serves on numerous review panels for the National Institutes of Health and the editorial boards of several major biomedical research journals. From 1984-1994, he was a Senior Investigator in the Diabetes Branch of the National Institutes of Health, and subsequently Professor and Associate Chair for Research in the Department of Pediatrics and Professor of Medicine at Oregon Health & Science University.